Clincosm LogoSign in Get a demo

type1 diabetes

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type1 Diabetes Trial in Charlottesville (Neural-net Artificial Pancreas, University of Virginia Model Predictive Control)

Recruiting
  • Type1 Diabetes
  • Neural-net Artificial Pancreas
  • University of Virginia Model Predictive Control
  • Charlottesville, Virginia
    University of Virginia Center for Diabetes Technology
May 27, 2023

Type1 Diabetes, Obesity Trial in Milan (Microbiome-targeted diet, Usual care diet)

Recruiting
  • Type1 Diabetes
  • Obesity
  • Microbiome-targeted diet
  • Usual care diet
  • Milan, Milano, Italy
  • +1 more
Mar 1, 2023

Type1 Diabetes Trial in United States (HCL, verapamil 120mg tablet, non-HCL)

Completed
  • Type1 Diabetes
  • HCL
  • +3 more
  • Palo Alto, California
  • +5 more
Oct 31, 2022

Type1 Diabetes Trial in Paris (Low carbohydrate diet)

Not yet recruiting
  • Type1 Diabetes
  • Low carbohydrate diet
  • Paris, France
    AP-HP - Pitié-Salpêtrière Hospital
Sep 7, 2022

Type1 Diabetes Trial in New Haven (Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP))

Completed
Has Results
  • Type1 Diabetes
  • Zone-Model Predictive Control Artificial Pancreas (ZMPC_AP)
  • New Haven, Connecticut
    Yale University
May 11, 2022

Type1 Diabetes Trial in United Kingdom (Aldesleukin, Placebo)

Active, not recruiting
  • Type1 Diabetes
  • Oxford, Oxfordshire, United Kingdom
  • +4 more
Dec 15, 2021

Type1 Diabetes Trial in Chula Vista, Aurora, Renton (350mg BID (700mg total daily) IMT-002, D-methyldopa, active formulation in

Completed
  • Type1 Diabetes
  • 350mg BID (700mg total daily) IMT-002, D-methyldopa, active formulation in capsule or Placebo, microcrystalline cellulose in capsule
  • +3 more
  • Chula Vista, California
  • +2 more
Aug 24, 2021

Type1 Diabetes Trial in Toulouse (Blood collection)

Withdrawn
  • Type1 Diabetes
  • Blood collection
  • Toulouse, Midi-Pyrénées, France
    CHU de Toulouse
Mar 30, 2020

Type1 Diabetes Trial in Thessaloniki (insulin)

Completed
  • Type1 Diabetes
  • Thessaloniki, Greece
    Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Dep
Jun 6, 2017

Type1 Diabetes Trial in Neuss (Insulin glargine new formulation HOE901)

Completed
  • Type1 Diabetes
  • Insulin glargine new formulation HOE901
  • Neuss, Germany
    Investigational Site Number 276001
Aug 9, 2013

Type1 Diabetes Trial in Chula Vista (Glargine)

Completed
  • Type1 Diabetes
  • Glargine
  • Chula Vista, California
    Profil Institute for clinical Research
Jan 24, 2013